Closed · RFA-DD-18-001 · CFDA 93.073 · Discretionary

Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) II

Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.

$700K-$1.1M
Award range
Closed
Status
February 22, 2018
Close date
6
Expected awards

The verdict

Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) II is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered $700,000 -- $1,100,000 across 6 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 639 other opportunities from Centers for Disease Control and Prevention - ERA.

$700K-$1.1M
award range
Closed
application status
6
expected awards
93.073
CFDA program

Archived opportunity record

Birth Defects Study To Evaluate Pregnancy exp… is closed (last close February 22, 2018). Check the agency catalog for replacement NOFOs. Centers for Disease Control and Prevention - ERA still indexes 639 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed February 22, 2018

Posted Dec 21 Closes Feb 22

Est. Total Funding

$28,500,000

Expected Awards

6

Instrument

Cooperative Agreement

Description

CDC has previously implemented population based case control studies of birth defects known as the National Birth Defects Prevention Study (NBDPS) for births from 1997-2011 and the Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS I) which started with births in 2014 and is ongoing. The purpose of BD-STEPS II is to identify causes of birth defects and stillbirths using epidemiologic and genetic research methods and provide information that could be translated into public health prevention messages. The activities under this NOFO will be supported by two separate but related funding components: Component A. BD-STEPS II Core. To support the epidemiological and genetic research capability of the Centers for Birth Defects Research and Prevention (CBDRP) through BD-STEPS. The intent of this BD-STEPS II is to carry out BD-STEPS using the same basic study design currently used by grantees with a focus on the key areas of: (1) maternal chronic diseases and their treatments; (2) infectious disease in pregnancy; and (3) medications. In BD-STEPS II, we will add focus on infectious causes of birth defects, and pilots will be conducted to determine feasibility of medication use validation. Both new sites and current BD-STEPS sites are encouraged to apply for this component. Component B. BD-STEPS stillbirth. To support the exploration of modifiable risk factors for stillbirths. The intent of this component is to conduct a case-control study of stillbirth risk factors using the BD-STEPS II Core interview and a follow-up interview with mothers affected by stillbirths and mothers of livebirths. To be funded for Component B, applicants must have a responsive application for Component A and receive Component A funding. Both new sites and current BD-STEPS sites are encouraged to apply for this component.

Catch-all / unrestricted eligibility mark · RFA-DD-18-001

Grants.gov marks Birth Defects Study To Evaluate Pregnancy exp… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). 54 other Centers for Disease Control and Prevention - ERA listings share this eligibility-code string (8% of 640).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Marcela Law mah7@cdc.gov

More from Centers for Disease Control and Prevention - ERA

Closed Closed November 5, 2026

US Travelers Health Research, Surveillance, Communication, and Outreach Network

View →
Closed Closed November 5, 2026

Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases

View →
Open Closes October 26, 2028

Occupational Safety and Health Training Project Grants (T03)

View →
Open Closes October 26, 2028

Occupational Safety and Health Education and Research Centers (T42)

View →
Open Closes September 30, 2030

RFA-PS-18-000

View →

What to do next

Birth Defects Study To Evaluate Pregnancy exp… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.073 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants